Peter Zage
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors (NCT03611595) | Peter Zage | 2018-08-28 |
Track Peter Zage automatically
Every clearance here is in the API, with alerts when new ones post.